Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder:A systematic review by the ISBD Targeting Cognition Task Force

MLA

Miskowiak, Kamilla W., et al. “Efficacy and Safety of Established and Off-Label ADHD Drug Therapies for Cognitive Impairment or Attention-Deficit Hyperactivity Disorder Symptoms in Bipolar Disorder:A Systematic Review by the ISBD Targeting Cognition Task Force.” Miskowiak , K W , Obel , Z K , Gugliemo , R , Bonnin , C D M , Bowie , C R , Balanzá-Martínez , V , Burdick , K E , Carvalho , A F , Dols , A , Douglas , K , Gallagher , P , Kessing , L V , Lafer , B , Lewandowski , K E , López-Jaramillo , C , Martinez-Aran , A , McIntyre , R S , Porter , R J , Purdon , S E , Schaffer , A , Stokes , P R A , Sumiyoshi , T , Torres , I J , Van Rheenen , T E , Yatham , L N , Young , A H , Vieta , E & Hasler , G 2024 , ’ Efficacy and Safety of Established and off-Label ADHD Drug Therapies for Cognitive Impairment or Attention-Deficit Hyperactivity Disorder Symptoms in Bipolar Disorder : A Systematic Review by the ISBD Targeting Cognition Task Force ’ , Bipolar Disorders , Vol. 26 , No. 3 , Pp. 216-239 , 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478334258&authtype=sso&custid=ns315887.

APA

Miskowiak, K. W., Obel, Z. K., Gugliemo, R., Bonnin, C. del M., Bowie, C. R., Balanzá-Martínez, V., Burdick, K. E., Carvalho, A. F., Dols, A., Douglas, K., Gallagher, P., Kessing, L. V., Lafer, B., Lewandowski, K. E., López-Jaramillo, C., Martinez-Aran, A., McIntyre, R. S., Porter, R. J., Purdon, S. E., … Hasler, G. (2024). Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder:A systematic review by the ISBD Targeting Cognition Task Force. Miskowiak , K W , Obel , Z K , Gugliemo , R , Bonnin , C D M , Bowie , C R , Balanzá-Martínez , V , Burdick , K E , Carvalho , A F , Dols , A , Douglas , K , Gallagher , P , Kessing , L V , Lafer , B , Lewandowski , K E , López-Jaramillo , C , Martinez-Aran , A , McIntyre , R S , Porter , R J , Purdon , S E , Schaffer , A , Stokes , P R A , Sumiyoshi , T , Torres , I J , Van Rheenen , T E , Yatham , L N , Young , A H , Vieta , E & Hasler , G 2024 , ’ Efficacy and Safety of Established and off-Label ADHD Drug Therapies for Cognitive Impairment or Attention-Deficit Hyperactivity Disorder Symptoms in Bipolar Disorder : A Systematic Review by the ISBD Targeting Cognition Task Force ’ , Bipolar Disorders , Vol. 26 , No. 3 , Pp. 216-239 .

Chicago

Miskowiak, Kamilla W., Zacharias K. Obel, Riccardo Gugliemo, Caterina del Mar Bonnin, Christopher R. Bowie, Vicente Balanzá-Martínez, Katherine E. Burdick, et al. 2024. “Efficacy and Safety of Established and Off-Label ADHD Drug Therapies for Cognitive Impairment or Attention-Deficit Hyperactivity Disorder Symptoms in Bipolar Disorder:A Systematic Review by the ISBD Targeting Cognition Task Force.” Miskowiak , K W , Obel , Z K , Gugliemo , R , Bonnin , C D M , Bowie , C R , Balanzá-Martínez , V , Burdick , K E , Carvalho , A F , Dols , A , Douglas , K , Gallagher , P , Kessing , L V , Lafer , B , Lewandowski , K E , López-Jaramillo , C , Martinez-Aran , A , McIntyre , R S , Porter , R J , Purdon , S E , Schaffer , A , Stokes , P R A , Sumiyoshi , T , Torres , I J , Van Rheenen , T E , Yatham , L N , Young , A H , Vieta , E & Hasler , G 2024 , ’ Efficacy and Safety of Established and off-Label ADHD Drug Therapies for Cognitive Impairment or Attention-Deficit Hyperactivity Disorder Symptoms in Bipolar Disorder : A Systematic Review by the ISBD Targeting Cognition Task Force ’ , Bipolar Disorders , Vol. 26 , No. 3 , Pp. 216-239 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1478334258&authtype=sso&custid=ns315887.